Literature DB >> 19797434

Anxiety and outcome in bipolar disorder.

William Coryell1, David A Solomon, Jess G Fiedorowicz, Jean Endicott, Pamela J Schettler, Lewis L Judd.   

Abstract

OBJECTIVE: Important differences exist between bipolar disorder with and without comorbid anxiety, but little is known about the long-term prognostic significance of coexisting anxiety in bipolar disorder. The authors sought to identify the anxiety features most predictive of subsequent affective morbidity and to evaluate the persistence of the prognostic relationship.
METHOD: Probands with bipolar I or II disorder from the National Institute of Mental Health Collaborative Depression Study were followed prospectively for a mean of 17.4 years (SD=8.4) and were characterized according to various manifestations of anxiety present at baseline. A series of general linear model analyses examined the relationship between these measures and the proportion of follow-up weeks in episodes of major depression and in episodes of mania or hypomania.
RESULTS: Patients whose episode at intake included a depressive phase spent nearly three times as many weeks in depressive episodes than did those whose intake episode was purely manic. Psychic and somatic anxiety ratings, but not the presence of panic attacks or of any lifetime anxiety disorder, added to the predictive model. Combined ratings of psychic and somatic anxiety were associated in a stepwise fashion with a greater proportion of weeks in depressive episodes, and this relationship persisted over the follow-up period.
CONCLUSIONS: The presence of higher levels of anxiety during bipolar mood episodes appears to mark an illness of substantially greater long-term depressive morbidity.

Entities:  

Mesh:

Year:  2009        PMID: 19797434      PMCID: PMC3551283          DOI: 10.1176/appi.ajp.2009.09020218

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  29 in total

1.  Anxiety as a correlate of response to the acute treatment of bipolar I disorder.

Authors:  U Feske; E Frank; A G Mallinger; P R Houck; A Fagiolini; M K Shear; V J Grochocinski; D J Kupfer
Journal:  Am J Psychiatry       Date:  2000-06       Impact factor: 18.112

2.  Rapid switching of mood in families with multiple cases of bipolar disorder.

Authors:  Dean F MacKinnon; Peter P Zandi; Elliot Gershon; John I Nurnberger; Theodore Reich; J Raymond DePaulo
Journal:  Arch Gen Psychiatry       Date:  2003-09

3.  A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness.

Authors:  Andrew C Leon; David A Solomon; Timothy I Mueller; Jean Endicott; John P Rice; Jack D Maser; William Coryell; Martin B Keller
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

4.  The long-term natural history of the weekly symptomatic status of bipolar I disorder.

Authors:  Lewis L Judd; Hagop S Akiskal; Pamela J Schettler; Jean Endicott; Jack Maser; David A Solomon; Andrew C Leon; John A Rice; Martin B Keller
Journal:  Arch Gen Psychiatry       Date:  2002-06

5.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

6.  Bipolar-panic disorder comorbidity within bipolar disorder families: a study of siblings.

Authors:  Carolyn J Doughty; J Elisabeth Wells; Peter R Joyce; Robin J Olds; Anne E S Walsh
Journal:  Bipolar Disord       Date:  2004-06       Impact factor: 6.744

7.  Is bipolar I disorder heterogeneous?

Authors:  Jules Angst; Regina Gerber-Werder; Hans-Ulrich Zuberbühler; Alex Gamma
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-04       Impact factor: 5.270

8.  Long-term symptomatic status of bipolar I vs. bipolar II disorders.

Authors:  Lewis L Judd; Pamela J Schettler; Hagop S Akiskal; Jack Maser; William Coryell; David Solomon; Jean Endicott; Martin Keller
Journal:  Int J Neuropsychopharmacol       Date:  2003-06       Impact factor: 5.176

9.  Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder.

Authors:  Ellen Frank; Jill M Cyranowski; Paola Rucci; M Katherine Shear; Andrea Fagiolini; Michael E Thase; Giovanni B Cassano; Victoria J Grochocinski; Bryan Kostelnik; David J Kupfer
Journal:  Arch Gen Psychiatry       Date:  2002-10

10.  Rapid switching of mood in families with familial bipolar disorder.

Authors:  Evaristus A Nwulia; Peter P Zandi; Melvin G McInnis; J Raymond DePaulo; Dean F MacKinnon
Journal:  Bipolar Disord       Date:  2008-07       Impact factor: 6.744

View more
  20 in total

Review 1.  An overview of mood disorders in the DSM-5.

Authors:  Jan Fawcett
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

2.  Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population.

Authors:  Regina Sala; Benjamin I Goldstein; Carmen Morcillo; Shang-Min Liu; Mariela Castellanos; Carlos Blanco
Journal:  J Psychiatr Res       Date:  2012-04-24       Impact factor: 4.791

3.  The influence of comorbid disorders on the episodicity of bipolar disorder in youth.

Authors:  S Yen; R Stout; H Hower; M A Killam; L M Weinstock; D R Topor; D P Dickstein; J I Hunt; M K Gill; T R Goldstein; B I Goldstein; N D Ryan; M Strober; R Sala; D A Axelson; B Birmaher; M B Keller
Journal:  Acta Psychiatr Scand       Date:  2015-10-17       Impact factor: 6.392

4.  Effects of anxiety on the long-term course of depressive disorders.

Authors:  William Coryell; Jess G Fiedorowicz; David Solomon; Andrew C Leon; John P Rice; Martin B Keller
Journal:  Br J Psychiatry       Date:  2011-10-07       Impact factor: 9.319

5.  Specific anxiety disorders and subsequent risk for bipolar disorder: a nationwide study.

Authors:  Sandra M Meier; Rudolf Uher; Ole Mors; Søren Dalsgaard; Trine Munk-Olsen; Thomas M Laursen; Manuel Mattheisen; Merete Nordentoft; Preben B Mortensen; Barbara Pavlova
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

6.  A randomized open comparison of long-acting injectable risperidone and treatment as usual for prevention of relapse, rehospitalization, and urgent care referral in community-treated patients with rapid cycling bipolar disorder.

Authors:  William V Bobo; Richard A Epstein; Alan Lynch; Tynya D Patton; Nicholas A Bossaller; Richard C Shelton
Journal:  Clin Neuropharmacol       Date:  2011 Nov-Dec       Impact factor: 1.592

7.  Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD.

Authors:  Thilo Deckersbach; Amy T Peters; Louisa Sylvia; Anna Urdahl; Pedro V S Magalhães; Michael W Otto; Ellen Frank; David J Miklowitz; Michael Berk; Gustavo Kinrys; Andrew Nierenberg
Journal:  Am J Psychiatry       Date:  2014-02       Impact factor: 18.112

8.  Age of onset and the prospectively observed course of illness in bipolar disorder.

Authors:  William Coryell; Jess Fiedorowicz; Andrew C Leon; Jean Endicott; Martin B Keller
Journal:  J Affect Disord       Date:  2012-10-11       Impact factor: 4.839

9.  Reexamining associations between mania, depression, anxiety and substance use disorders: results from a prospective national cohort.

Authors:  M Olfson; R Mojtabai; K R Merikangas; W M Compton; S Wang; B F Grant; C Blanco
Journal:  Mol Psychiatry       Date:  2016-05-03       Impact factor: 15.992

10.  Effects of comorbid anxiety disorders on the longitudinal course of pediatric bipolar disorders.

Authors:  Regina Sala; Michael A Strober; David A Axelson; Mary Kay Gill; Josefina Castro-Fornieles; Tina R Goldstein; Benjamin I Goldstein; Wonho Ha; Fangzi Liao; Satish Iyengar; Shirley Yen; Heather Hower; Jeffrey Hunt; Daniel P Dickstein; Neal D Ryan; Martin B Keller; Boris Birmaher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-10-17       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.